Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
We are very excited to launch our new website! Please take a few moments to click around and explore...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...